This brand name is authorized in Nigeria.
The drug DIOARTEM contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
C7D6T3H22J - ARTEMETHER
|
|
Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. |
|
2
|
UNII
F38R0JR742 - LUMEFANTRINE
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-6807 | Tablet | DIOARTEM 20/120 TABLETS TAB 20 mg; 120 mg 1X24 | 109 RNW-PP-280721 DIOARTEM 20/120 TABLETS ARTEMETHER LUMEFANTRINE TABLETS Each tablet contains Artemether 20mg, Lumefantrine 120mg, Excipients Qs B4-6807 Drugs Imported Products 1X24 Over The Counter (OTC) 9/21/2022 VIRGIN SP1983 PHARMACY LTD, PLOT 392 NEW GRA ALONG DENTAL SCHOOL ROAD 8055555858 virginsppharma@gmail.com ALPA LABORATORIES LTD,., 33/2, A, B ROAD, INDORE (M.P.) INDIA, India | 06/07/2023 |
| B4-6834 | Tablet | DIOARTEM TABLET TAB 80 mg; 480 mg 16TABS | 108 RNW-PP-281766 DIOARTEM TABLET ANTIMALARIAL Each tablet contains Artemether 80mg, Lumefantrine USP 480mg, Excipients q.s. B4-6834 Drugs Imported Products 16TABS Over The Counter (OTC) 9/21/2022 VIRGIN SP1983 PHARMACY LTD, PLOT 392 NEW GRA ALONG DENTAL SCHOOL ROAD 8055555858 virginsppharma@gmail.com ALPA LABORATORIES LTD,., 33/2, A, B ROAD, INDORE (M.P.) INDIA, India | 06/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| P01BF01 | Artemether and lumefantrine | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-6807, B4-6834 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.